Bernard Masquelier

Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a European multicohort study

Linda Wittkop, Huldrych F. Günthard, Frank de Wolf et al. · The Lancet Infectious Diseases · 2011 · 387 citations · Full text

Life Sciences, Infectious Diseases, Pharmacotherapy +17

Low-frequency drug-resistant HIV-1 and risk of virological failure to first-line NNRTI-based ART: a multicohort European case–control study using centralized ultrasensitive 454 pyrosequencing

Alessandro Cozzi‐Lepri, Marc Noguera-Julián, Francesca Di Giallonardo et al. · Journal of Antimicrobial Chemotherapy · 2014 · 126 citations · Full text

Life Sciences, Infectious Diseases, Hiv Control +16

French National Sentinel Survey of Antiretroviral Drug Resistance in Patients With HIV-1 Primary Infection and in Antiretroviral-Naive Chronically Infected Patients in 2001-2002

Diane Descamps, Marie‐Laure Chaix, Patrice André et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2005 · 124 citations

Life Sciences, Infectious Diseases, Pharmacology +17

Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France

Marie‐Laure Chaix, Diane Descamps, M Harzic et al. · AIDS · 2003 · 114 citations

Life Sciences, Infectious Diseases, Microbiology +17

Human Immunodeficiency Virus Type 1 Genotypic and Pharmacokinetic Determinants of the Virological Response to Lopinavir-Ritonavir-Containing Therapy in Protease Inhibitor-Experienced Patients

Bernard Masquelier, Dominique Breilh, D. Neau et al. · Antimicrobial Agents and Chemotherapy · 2002 · 111 citations · Full text

Life Sciences, Pharmacokinetics, Pharmacology +17